Clinical trial for Ebola vaccine developed at UW–Madison underway in Japan
December 13, 2019
Written by By Kelly April Tyrrell
As of this week, a phase one clinical trial to test a potential new Ebola vaccine developed by researchers at the University of Wisconsin–Madison is underway in Japan.
Fifteen healthy young men* will receive two doses of the experimental vaccine. If the first group tolerates the vaccine, an additional group of up to 20 volunteers will receive a higher dose of the vaccine. Read more.
Published December 13, 2019 by University of Wisconsin-Madison
Share this story
‹ More Featured Studies